January 14, 2014 / 12:42 PM / in 4 years

MARKET PULSE-Stratasys, Amerigas, RAIT Financial, Yum Brands

(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s) U.S. stock index futures advanced on Tuesday a day after the S&P 500 suffered its biggest drop in two months as investors prepared for retail sales data and the first round of earnings from major banks. Dow Jones industrial average futures were unchanged at 16,214, S&P 500 futures were up 0.21 percent at 1,819 and Nasdaq 100 futures were up 0.13 percent at 3,514.

** JPMORGAN CHASE & CO, Monday close $57.7

The biggest U.S. bank by assets reported a 7.3 percent drop in quarterly profit after it paid penalties to the government for not reporting suspicions of fraud by Ponzi-scheming client Bernie Madoff.

** STRATASYS LTD, Monday close $130, -1.92 pct premarket

The 3D printer maker estimated full-year adjusted profit way below Wall Street estimates as it warned expenses would rise significantly in 2014.

** TIME WARNER CABLE, Monday close $132.4, +1.65 pct premarket

** CHARTER COMMUNICATIONS INC, Monday close $134.22

Charter Communications on Monday formally offered to acquire larger rival Time Warner Cable for $37.3 billion, sparking what is likely to be a contentious battle for control of the No. 2 U.S. cable operator.

** AMERIGAS PARTNERS LP, Monday close $44.63, -5.29 pct premarket

The propane gas distributor said late on Monday that an affiliate of Energy Transfer Partners LP has begun a public offering of 8 million AmeriGas shares it owns. AmeriGas bought Energy Transfer Partners’s propane business for $2.8 billion in October 2011.

** RAIT FINANCIAL TRUST, Monday close $8.78, -3.30 pct premarket

The real estate investment trust said it had commenced an offering of 10 million common shares. The company plans to use the proceeds of the offering for investments and general trust purposes.

** TARGET CORP, Monday close $61.5

Democratic lawmakers called on Monday for a congressional inquiry into the hacking of credit and debit card data of tens of millions of customers of No. 3 U.S. retailer Target Corp during the holiday shopping season.

** GOOGLE INC, Monday close $1,122.98, +1.52 pct premarket

Google took its biggest step to go deeper into consumers’ homes, announcing a $3.2 billion deal to buy smart thermostat and smoke alarm-maker Nest Labs Inc, scooping up a promising line of products and a prized design team led by the “godfather” of the iPod.

** APPLE INC, Monday close $535.73, +0.58 pct premarket

Apple lost a bid on Monday to block an antitrust monitor appointed after a judge found that the company had conspired to fix e-book prices.

** NASDAQ OMX GROUP, Monday close $39.15

** MCGRAW HILL FINANCIAL INC, Monday close $76.63

Exchange operator Nasdaq and index provider S&P Dow Jones Indices said they are interested in acquisitions to grow their index businesses, in a sign the sector could see a wave of deals as investors pour tens of billions of dollars into portfolios that track benchmarks.

** FOREST LABORATORIES INC, Monday close $67.73

Hungarian drugmaker Richter has dismissed as “entirely unrealistic” market speculation that U.S. peer Forest Laboratories might consider it as a potential takeover target.

** YUM BRANDS INC, Monday close $73.41, -0.56 pct premarket

Yum Brands on Monday said December sales at established restaurants in China, its top market, rose a smaller-than-expected 2 percent after weakness at its Pizza Hut Casual Dining chain weighed on a recovery at KFC, which is recovering from a food safety scare and avian flu worries.

** ACTAVIS PLC, Monday close $181.29

** MYLAN INC, Monday close $45.24

** PFIZER INC, Monday close $30.54

Drugmakers Valeant Pharmaceuticals International Inc , Actavis and Mylan have all expressed interest in buying Pfizer Inc’s branded generics business, but no active discussions are going on at this time, according to three people close to the matter.


U.S. based-Regeneron Pharmaceuticals and Germany’s Bayer AG said they would co-develop an antibody for use in combination with Eylea, their treatment for a form of age-related blindness.

** ELI LILLY, Monday close $52.07

Danish biotech company Genmab has entered into a research collaboration with U.S. pharmaceutical company Eli Lilly involving its DuoBody technology platform.


The Chinese company said its solar panels would be sold in the high-margin Japanese market by XSOL Co Ltd from mid January.

** BENCHMARK ELECTRONICS INC, Monday close $22.51, +3.07 pct after market

The electronic manufacturing services provider said late on Monday it expected to report fourth-quarter results above the high end of its forecast range. The company said in October it expected fourth-quarter earnings of 34 cents-38 cents per share, excluding items, on sales of $685 million-$715 million. Analysts on average expected earnings of 36 cents per share on revenue of $701.1 million, according to Thomson Reuters I/B/E/S. (Compiled by Varun Aggarwal in Bangalore; Edited by Don Sebastian)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below